These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24277375)

  • 21. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of the influence of X-ray repair cross-complementing group 3 rs861539 polymorphism and cutaneous melanoma susceptibility.
    Zeng Y; Ma F; Gao W; Wang Y; Liu C
    Arch Dermatol Res; 2016 Apr; 308(3):173-81. PubMed ID: 26922354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. XPC Lys939Gln polymorphism, smoking and risk of sporadic colorectal cancer among Malaysians.
    Ahmad Aizat AA; Siti Nurfatimah MS; Aminudin MM; Ankathil R
    World J Gastroenterol; 2013 Jun; 19(23):3623-8. PubMed ID: 23801864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between XPC Lys939Gln polymorphism and prostate cancer risk: an updated meta-analysis based on 3039 cases and 3253 controls.
    Wu H; Lv Z; Wang X; Zhang L; Mo N
    Int J Clin Exp Med; 2015; 8(10):17959-67. PubMed ID: 26770390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of polymorphisms in nucleotide excision repair pathway genes with susceptibility to cutaneous melanoma.
    Hashemzehi A; Ghadyani M; Asadian F; Dastgheib SA; Kargar S; Neamatzadeh H; Akbarian E; Emarati A
    Klin Onkol; 2021; 34(5):350-355. PubMed ID: 34702042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
    Sankhwar M; Sankhwar SN; Bansal SK; Gupta G; Rajender S
    Sci Rep; 2016 Jun; 6():27018. PubMed ID: 27246180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of XPG rs17655G>C and XPF rs1799801T>C Polymorphisms with Susceptibility to Cutaneous Malignant Melanoma: Evidence from a Case-Control Study, Systematic Review and Meta-Analysis.
    Mohammadreza Niktabar S; Alireza Dastgheib S; Heiranizadeh N; Kargar S; Raee-Ezzabadi A; Jarahzadeh MH; Mohsen Miresmaeili S; Zare-Shehneh M; Neamatzadeh H
    Klin Onkol; 2020; 33(3):184-194. PubMed ID: 32683874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.
    Wei X; Chen D; Lv T
    Mol Biol Rep; 2013 Jan; 40(1):567-72. PubMed ID: 23096083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a meta-analysis of 17 case-control studies.
    Zhu HL; Bao JM; Lin PX; Li WX; Zou ZN; Huang YE; Chen Q; Shen H
    Asian Pac J Cancer Prev; 2014; 15(16):6619-25. PubMed ID: 25169498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences.
    Letkova L; Matakova T; Musak L; Sarlinova M; Krutakova M; Slovakova P; Kavcova E; Jakusova V; Janickova M; Drgova A; Berzinec P; Halasova E
    Mol Biol Rep; 2013 Sep; 40(9):5261-73. PubMed ID: 23673479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma: Evidence based on 4306 patients and 4779 controls.
    Qin F; Gao SL; Xu K; Su QX; Zhang Z; Shi L; Zhu LJ; Zhang LF; Zuo L
    Medicine (Baltimore); 2020 Jul; 99(28):e21160. PubMed ID: 32664151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.
    Gangwar R; Mandhani A; Mittal RD
    J Cancer Res Clin Oncol; 2010 May; 136(5):779-86. PubMed ID: 19924443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
    Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis.
    Dai QS; Hua RX; Zhang R; Huang YS; Hua ZM; Yun CT; Zeng RF; Long JT
    Gene; 2013 Oct; 528(2):335-42. PubMed ID: 23892089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association of XPC gene polymorphisms with breast cancer risk].
    Wu YY; Ma XY; Yao KY; Li QL; Chen K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 May; 40(3):252-8. PubMed ID: 21671483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variants of DNA repair gene XPC modulating susceptibility to cervical cancer in North India.
    Gangwar R; Mittal B; Srivastava S; Singh H; Mittal RD
    Oncol Res; 2010; 18(7):329-35. PubMed ID: 20377134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A 1:1 matched case-control study on the interaction between HBV, HCV infection and DNA repair gene XPC Ala499Val, Lys939Gln for primary hepatocellular carcinoma].
    Cai XL; Gao YH; Yu ZW; Wu ZQ; Zhou WP; Yang Y; Xu Y; Song SF; Chen SD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):942-5. PubMed ID: 20193233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
    Liu B; Shen T
    Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
    Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
    Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
    Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z
    Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.